439 related articles for article (PubMed ID: 12440337)
21. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis.
Decena DC; Co JT; Manalastas RM; Palaypayon EP; Padolina CS; Sison JM; Dancel LA; Lelis MA
J Obstet Gynaecol Res; 2006 Apr; 32(2):243-51. PubMed ID: 16594932
[TBL] [Abstract][Full Text] [Related]
22. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment.
Klebanoff MA; Hauth JC; MacPherson CA; Carey JC; Heine RP; Wapner RJ; Iams JD; Moawad A; Miodovnik M; Sibai BM; vanDorsten JP; Dombrowski MP;
Am J Obstet Gynecol; 2004 Feb; 190(2):363-70. PubMed ID: 14981375
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance associated with the treatment of bacterial vaginosis.
Beigi RH; Austin MN; Meyn LA; Krohn MA; Hillier SL
Am J Obstet Gynecol; 2004 Oct; 191(4):1124-9. PubMed ID: 15507930
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
Wang FM; Qian XD; Xu H; Yu HY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2201-3. PubMed ID: 19080672
[TBL] [Abstract][Full Text] [Related]
25. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
[TBL] [Abstract][Full Text] [Related]
26. Effective of metronidazole to bacterial flora in vagina and the impact of microbes on live birth rate during intracytoplasmic sperm injection (ICSI).
Selim SA; El Alfy SM; Aziz MH; Mohamed HM; Alasbahi AA
Arch Gynecol Obstet; 2011 Dec; 284(6):1449-53. PubMed ID: 21331540
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study of combined local treatment (sulfadimidine, metronidazole and nystatin) and the standard monotherapy in uncomplicated bacterial vaginosis].
Milánkovits M; Baksay L; Plachy J
Orv Hetil; 2002 Dec; 143(51):2835-40. PubMed ID: 12638310
[TBL] [Abstract][Full Text] [Related]
29. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects.
Brandt M; Abels C; May T; Lohmann K; Schmidts-Winkler I; Hoyme UB
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):158-62. PubMed ID: 18775597
[TBL] [Abstract][Full Text] [Related]
30. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
[TBL] [Abstract][Full Text] [Related]
31. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
Plummer EL; Bradshaw CS; Doyle M; Fairley CK; Murray GL; Bateson D; Masson L; Slifirski J; Tachedjian G; Vodstrcil LA
PLoS One; 2021; 16(2):e0246953. PubMed ID: 33571286
[TBL] [Abstract][Full Text] [Related]
32. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.
McDonald HM; O'Loughlin JA; Vigneswaran R; Jolley PT; McDonald PJ
Obstet Gynecol; 1994 Sep; 84(3):343-8. PubMed ID: 8058228
[TBL] [Abstract][Full Text] [Related]
33. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.
Sobel JD; Ferris D; Schwebke J; Nyirjesy P; Wiesenfeld HC; Peipert J; Soper D; Ohmit SE; Hillier SL
Am J Obstet Gynecol; 2006 May; 194(5):1283-9. PubMed ID: 16647911
[TBL] [Abstract][Full Text] [Related]
34. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
[TBL] [Abstract][Full Text] [Related]
35. [New alternatives in the treatment of bacterial vaginosis].
Luis Arredondo J; Higuera F; Narcio ML; Casanova G; Beltrán M
Ginecol Obstet Mex; 1994 Aug; 62():226-34. PubMed ID: 7959144
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
[TBL] [Abstract][Full Text] [Related]
37. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
38. [Current treatment of bacterial vaginosis].
Borisov I
Akush Ginekol (Sofiia); 1999; 38(1):76-8. PubMed ID: 11965732
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of bacterial vaginosis in 76 cases].
Yu X; Weng L; Song X
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):229-31. PubMed ID: 8758780
[TBL] [Abstract][Full Text] [Related]
40. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]